Objective-microRNA-155 (miR155) plays a critical role in immunity and macrophage inflammation. We aim to investigate the role of miR155 in atherogenesis. Approach and Results-Quantitative real-time polymerase chain reaction showed that miR155 was expressed in mouse and human atherosclerotic lesions. miR155 expression in macrophages was correlated positively with proinflammatory cytokine expression. Lentivirus-mediated overexpression of miR155 in macrophages enhanced their inflammatory response to lipopolysaccharide through targeting suppressor of cytokine signaling-1 and impaired cholesterol efflux from acetylated low-density lipoprotein-loaded macrophages, whereas deficiency of miR155 blunted macrophage inflammatory responses and enhanced cholesterol efflux possibly via enhancing lipid loading-induced macrophage autophagy. We next examined the atherogenesis in apolipoprotein E-deficient (apoE −/− ) and miR155 −/− /apoE −/− (double knockout) mice fed a Western diet. Compared with apoE −/− mice, the double knockout mice developed less atherosclerosis lesion in aortic root, with reduced neutral lipid content and macrophages. Flow cytometric analysis showed that there were increased number of regulatory T cells and reduced numbers of Th17 cells and CD11b+/Ly6C high cells in the spleen of double knockout mice. Peritoneal macrophages from the double knockout mice had significantly reduced proinflammatory cytokine expression and secretion both in the absence and presence of lipopolysaccharide stimulation. To determine whether miR155 in leukocytes contributes to atherosclerosis, we performed a bone marrow transplantation study. Deficiency of miR155 in bone marrow-derived cells suppressed atherogenesis in apoE −/− mice, demonstrating that hematopoietic cell-derived miR155 plays a critical role.
A therosclerosis is both a lipid storage disease and a chronic inflammatory process. [1] [2] [3] [4] [5] [6] Although lipid accumulation in the intimal space and local inflammation are closely linked in atherogenesis, macrophages are pivotal players in the process through both maintaining vessel wall lipid homeostasis and orchestrating inflammatory responses. 7 Numerous molecules take part in the pathological transformation of macrophages in atherogenesis, and the complex signaling network underlying macrophage inflammation in the context of atherogenesis is far from clear.
MicroRNAs (miRs) are short noncoding RNA molecules that regulate gene expression post-transcriptionally through base pairing with mRNAs, resulting in either translational repression or mRNA degradation. 8 They are estimated to regulate up to a third of all human genes 9 and play critical roles in many physiological or pathological processes, including cell differentiation, immunity development, and cancer transformation. Therefore, miRs are emerging as new targets for the diagnosis and therapy of human diseases, 10 including dyslipidemia and atherosclerosis. MicroRNA-155 (miR155) is encoded in the B-cell integration cluster (Bic) gene 11 and is prominently expressed in many hematopoietic cell types 12 ; it has been demonstrated to be oncogenic and play a crucial role in immune response regulation. [13] [14] [15] In macrophages, a microarray analysis found that miR155 was among the few miRs that were substantially upregulated by Toll-like receptor (TLR) ligands. 16, 17 Although the functional relevance of macrophage miR155 expression is unclear, studies indicated that miR155 may enhance inflammatory response by stimulating the release of inflammatory mediators by targeting several negative feedback molecules including suppressor of cytokine signaling (SOCS)-1 and SH2 domain-containing inositol 5'-phosphatase (SHIP)-1. However, it may also attenuate inflammatory response under other circumstances. [18] [19] [20] [21] [22] Given the critical role of macrophage inflammation in atherogenesis, it is imperative to define the effect of miR155 expression and regulation on atherogenesis. Recently, 2 studies showed opposite results on the effects of bone marrow cell miR155 deficiency on atherosclerosis. In 1 study, Donners et al 23 reported that bone marrow miR155 deficiency increased atherosclerosis in low-density lipoprotein receptor (LDLR) −/− mice fed a high-fat diet by generating a more proatherogenic immune cell profile and a more proinflammatory monocyte/macrophage phenotype. In the other study, Nazari-Jahantigh et al 24 showed that miR155 promoted atherosclerosis in a partial carotid ligation apolipoprotein E-deficient (apoE −/− ) mouse model by repressing B-cell lymphoma 6 protein in macrophages, thus enhancing vascular inflammation.
In the current study, we first show that miR155 expression was increased in mouse and human aorta atherosclerotic lesions and that miR155 expression was positively correlated with proinflammatory cytokine expression under various conditions. Furthermore, increased miR155 expression conferred macrophages a proatherogenic phenotype, including enhanced inflammatory responses to lipopolysaccharide (LPS) and impaired cholesterol efflux on cholesterol loading, whereas miR155 deficiency rendered macrophage less inflammatory. Moreover, we compared the atherosclerosis development in apoE −/− and apoE −/− /miR155 −/− mice and showed that miR155 deficiency in apoE −/− mice attenuated atherogenesis by reducing macrophage inflammation. This result was confirmed by bone marrow transplantation study showing that deficiency of miR155 in bone marrow-derived cells reduced atherogenesis in apoE −/− mice.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results miR155 Is Upregulated in Mouse and Human Aortic Atherosclerotic Lesions
We first examined miR155 expression in mouse aorta atherosclerotic lesions by quantitative real-time polymerase chain reaction (qRT-PCR). miR155 expression was determined in aorta segments from 4-month-old wild-type (WT) C57BL/6 mice and 3-to 7-month-old apoE −/− /LDLR −/− mice. The aortas of the apoE −/− /LDLR −/− mice were dissected into atherosclerotic and nonlesion (normal) segments under microscope. Total RNAs (including miRs) were extracted from the aorta segments for qRT-PCR analysis of miR155 and tumor necrosis factor (TNF) α expression. Figure IA in the online-only Data Supplement shows that the atherosclerotic segments of aortas from apoE −/− /LDLR −/− mice expressed higher levels of miR155 and TNFα compared with the nonatherosclerotic aorta segments of the same apoE −/− / LDLR −/− mice, as well as aortas from WT mice.
We further examined miR155 expression in human aorta atherosclerotic lesions by qRT-PCR. Lesional tissue and the surrounding normal tissue from human aortas were dissected, and total RNA was extracted for measurement of human miR155 and TNFα expression. Figure IB in the online-only Data Supplement shows that compared with surrounding normal aortic tissue, human aortic atherosclerotic lesion had 2-fold increase in miR155 expression, along with a 7-fold increase in TNFα expression.
miR155 Expression Is Upregulated in Macrophages by TLR4 Activation and Is Correlated With Inflammatory Cytokines
It is known that a TLR4 ligand, LPS, stimulates miR155 expression in macrophages. 16 We first examined whether a more physiologically relevant atherogenic TLR4 ligand, minimally oxidized low-density lipoprotein (mmLDL), induces miR155 expression in macrophages. LDL was minimally oxidized by incubation with copper sulfate (10 μmol/L; 3 hours) to generate mmLDL. The mmLDL was used to stimulate thioglycollate-elicited peritoneal macrophages from WT C57Bl/6 mice, apoE −/− /LDLR −/− mice, and TLR4 −/− mice. Cells were also stimulated with LPS as a positive control. The macrophages were incubated for 6 hours with serum-free DMEM, with the addition of either mmLDL (100 μg/mL) or LPS (100 ng/mL). qPCR was performed to quantify miR155 expression. Figure IIA in the online-only Data Supplement shows that both mmLDL and LPS significantly increased macrophage miR155 expression in a TLR4-dependent manner, and the responses were enhanced significantly in macrophages from apoE −/− /LDLR −/− mice than in those from WT C57Bl/6 mice. We further measured miR155 expression levels in macrophages from mice of different genotypes, including WT C57Bl/6, LDLR −/− , apoE −/− , apoE −/− /LDLR −/− , and TLR4 −/− , and subjected to various treatments, including DMEM control, mmLDL or LPS stimulation, or acetylated LDL loading. Concurrently, we also measured the expression levels of inflammatory cytokines in these macrophages. In Figure IIB in the online-only Data Supplement, we plotted the correlation of miR155 levels and TNFα or interleukin-6 (IL-6) mRNA levels in the macrophages, showing a clear positive correlation between miR155 expression levels and TNFα or IL-6 levels.
Overexpression of miR155 Alters Macrophage Function
To investigate further the relationship between miR155 expression and macrophage function, we generated a lentiviral vector 25 used for the generation of the B-lymphocyte-specific miR155 transgenic mouse model. The expression of miR155 and GFP is under the control of the universal promoter elongation factor-1α ( Figure IIIA in the online-only Data Supplement). The transduction efficiency for primary macrophages is >90% when a multiplicity of infection of 30 is used as demonstrated by flow cytometric analysis of GFP expression (data not shown). The overexpression of mature mouse miR155 was confirmed in PWPI-miR155-GFP lentivirustransduced mouse peritoneal macrophages by qPCR (increased by > 30-fold compared with PWPI-GFP lentivirus transduced cells; Figure IIIB in the online-only Data Supplement). We transduced peritoneal macrophages from WT C57Bl/6 mice with PWPI-miR155-GFP or control PWPI-GFP lentiviruses and examined inflammatory cytokine expression. Interestingly, we found that miR155 overexpression alone did not increase TNFα expression in macrophages. However, when stimulated with LPS, the PWPI-miR155-GFP lentivirus-transduced macrophages displayed a 3-fold increase in TNFα expression compared with the control group (P=0.022; Figure 1A ).
To investigate the molecular mechanisms through which miR155 enhances macrophage inflammatory responses to proinflammatory stimuli, protein levels of SOCS-1 and SHIP-1 were detected in miR155-overexpressing macrophages. It has been reported that SOCS-1 and SHIP-1, 2 negative regulators of the TLR4-mediated inflammatory pathway, are miR155 target proteins in monocytes and macrophages. Therefore, we examined whether miR155 overexpression reduced protein levels of SOCS-1 and SHIP-1 in mouse peritoneal macrophages. The transduced macrophages were stimulated with LPS (100 ng/mL) for 0, 6, or 24 hours. Protein levels of SOCS-1 and SHIP-1 were examined by Western blot using β-actin as a loading control. The results showed that mouse miR155 overexpression substantially reduced SOCS-1 levels Figure 1 . MicroRNA-155 (miR155) enhances macrophage inflammatory responses by targeting SOCS-1. A, Mouse macrophages were transduced with PWPI-GFP or PWPI-miR155-GFP lentiviruses. The transduced cells were treated with lipopolysaccharide (LPS; 50 ng/ mL) for 6 hours before mRNA was extracted for quantitative polymerase chain reaction (qPCR) measurement of tumor necrosis factor (TNF) α expression (n=3 for each group). B, The transduced cells were treated with LPS (50 ng/mL) for 6 to 24 hours. Cell lysates were used for detection of SOCS-1 and SHIP-1 levels by Western blotting. C, Western blots in 3 experiments were analyzed for the relative protein levels (*P<0.05). D-F, Wild-type (WT) and miR155 −/− mouse peritoneal macrophages were treated with LPS (10 ng/mL), Pam3CSK4 (500 ng/mL), FSl-1 (100 ng/mL), poly (I:C) (10 μg/mL), and ODN1668 (1 μmol/L) for 6 hours, respectively. Total RNA was extracted and reverse transcribed into cDNA as template to detect the inflammatory cytokines (D, TNFα; E, interleukin-6 [IL-6]; F, IL-1β) by qPCR (n=3; *P<0.05, **P<0.01).
in mouse peritoneal macrophages, whereas SHIP-1 levels were not changed ( Figure 1B and 1C ).
miR155 Deficiency Attenuates Macrophage Inflammatory Response
To confirm the function of miR155 in macrophage inflammatory responses, we compared the macrophages from WT and miR155 −/− mice. We treated WT and miR155 −/− mouse macrophages with different TLR ligand, including LPS (TLR4 ligand), Pam3CSK4 (TLR1/2 ligand), Fsl-1 (TLR2/6 ligand), Poly(I:C) (TLR3 ligand), and ODN1668 (TLR9 ligand). We found that miR155 deficiency diminished the expression of TNFα, IL-6, and IL-1β induced by all of above TLR ligands, indicating that miR155 deficiency dampened macrophage inflammatory signaling triggered by multiple TLR activation, including TLR2, TLR4, TLR3, and TLR9 ( Figure 1C ).
miR155 Expression Affects Macrophage Cholesterol Efflux
It has been well demonstrated that macrophage inflammation and cholesterol homeostasis are intimately connected. The contact point is the peroxisome proliferator-activated receptor-liver X receptor axis. To examine whether miR155 affects macrophage cholesterol homeostasis, we first measured the cholesterol efflux from the macrophages transduced with PWPI-miR155-GFP lentiviruses. Figure 2A shows that, compared with control PWPI-GFP lentivirus-transduced macrophages, miR155-overexpressing macrophages displayed impaired cholesterol efflux to apolipoprotein A-I (a 10% decrease; P=0.035), but efflux to DMEM (baseline cholesterol diffusion) was not changed. We next used peritoneal macrophages from miR155 −/− or WT mice to measure cholesterol efflux. We found that miR155 deficiency significantly increased the cholesterol efflux to apolipoprotein A-I (by 45%; P=0.0002), whereas cholesterol efflux to high-density lipoprotein was not significantly different ( Figure 2B ). To examine molecular mechanisms underlying the increased cholesterol efflux in miR155 −/− macrophages, we loaded WT and miR155 −/− macrophages with acetylated LDL for 48 hours, qPCR was used to quantify the mRNA expression, and Western blot was performed to compare the protein expression of ATP-binding cassette transporter A (ABCA1) and ABCG1. Surprisingly, we found that ABCA1 and ABCG1 in miR155 −/− macrophages were comparable to those in WT macrophages ( Figure 2C and 2D), indicating that increased cholesterol efflux in miR155 −/− macrophages was not because of increased expression of cholesterol efflux genes, ABCA1 and ABCG1. Recent studies have shown that macrophage autophagy enables cholesterol efflux via presenting free cholesterol to cell membrane. 26, 27 We thus examined whether miR155 deficiency increases autophagy of macrophages, especially under cholesterol-loading condition. We performed Western blot to measure light chain 3 protein in macrophages and found that both forms of light chain 3 (light chain 3-I and light chain 3-II) were significantly increased in miR155 −/− macrophages, both in unloaded and in acetylated LDL-loaded cells, compared with WT macrophages (Figure 2E and 2F), indicating that miR155 deficiency enhances macrophage autophagy.
miR155 Deficiency Attenuates Atherogenesis in Mice
Because macrophage miR155 deficiency attenuated inflammatory responses and enhanced cholesterol efflux, we next examined whether miR155 deficiency protects mice from developing atherosclerotic lesions. Female apoE −/− and miR155/apoE double knockout (DKO) mice at 8 weeks of age were fed a Westerntype diet to raise plasma cholesterol levels and to induce atherosclerosis. After 12 weeks on the Western diet, the mice were euthanized. Body weight, plasma cholesterol, and triglyceride levels, as well as fast protein liquid chromatography lipoprotein profiles at the end point, were comparable between both groups of mice ( Figure IV in the online-only Data Supplement). As visualized by hematoxylin and eosin staining, mean lesion area was 0.48±0.03 mm 2 in aortic roots of apoE −/− mice and 0.30±0.04 mm 2 in DKO mice, reflecting a 37% reduction ( Figure 3A) . However, atherosclerotic lesion area in en face aortas was not statistically significantly different between apoE −/− and DKO mice ( Figure V in the online-only Data Supplement).
We further stained the lesions for neutral lipid with Oil Red O. The results showed that lipid staining area in the lesions of DKO mice (0.20±0.02 mm 2 ) was significantly smaller than that in apoE −/− mice (0.31±0.02 mm 2 ), reduced by 36% ( Figure 3B ). We stained lesional macrophages using a mouse macrophage specific antibody macrophage/monocytes antibody-2 and found the DKO mice displayed a ≈48% less macrophage area (0.13±0.02 mm 2 ) in aortic root atherosclerotic lesions compared with apoE −/− mice (0.26±0.03 mm 2 ; Figure 3C ). However, collagen content in lesions as determined by Movat's Pentachrome staining was not significantly different between the 2 groups ( Figure VI in the online-only Data Supplement). miR155 is profoundly involved in immunity, modulating immune cell differentiation and maturation. We thus examined whether miR155 deficiency altered leukocyte populations in our atherosclerotic mouse model using flow cytometry. Our data showed that in DKO mouse spleen, the percentages of T cells (CD3+/CD4+, and CD3+/CD8+) and Th17 cells (CD4+/ IL17+) were decreased and those of B cells (CD19+) and regulatory T cells (CD4+/FoxP3+) were increased compared with those in apoE −/− mouse spleens. Although the percentage of CD11+/Ly6C+ cells was not different in apoE −/− or DKO mouse spleens, the percentage of CD11+/Ly6C high subpopulation was significantly reduced in DKO mouse spleens (Figure 4) .
At the end point, we obtained peritoneal macrophages from apoE −/− and DKO mice and treated the macrophage with vehicle or LPS (100 ng/mL) for 6 or 24 hours. We found that both in the absence and presence of LPS stimulation DKO macrophages expressed TNFα, IL-6, and IL-1β mRNAs at significantly lower levels than apoE −/− macrophages after 6 hours of stimulation ( Figure 5A ). ELISA analysis showed that after 24 hours of incubation, DKO macrophage-conditioned medium contained significantly lower levels of TNFα and IL-6 compared with the conditioned medium of apoE −/− macrophages ( Figure 5B ). These data suggest that miR155 deficiency in lipoprotein-loaded apoE −/− macrophages diminished their inflammatory responses. We also measured TNFα and IL-6 concentrations in mouse plasma and found that the concentration of IL-6 was significantly reduced in DKO mice than in apoE −/− mice; however, the plasma levels of TNFα showed no difference in 2 groups of mice.
Bone Marrow miR155 Deficiency Reduces Atherosclerosis in Mice
To dissect further the role of myeloid cell miR155 expression in atherogenesis, we performed a bone marrow transplantation study. We transplanted bone marrow cells from apoE −/− or DKO mice to lethally irradiated apoE −/− mice of 12 weeks of age. After 4 weeks, mice were fed a Western diet for 16 weeks. As in the study using whole body knockouts, apoE −/− recipient mice with miR155 deficiency in bone marrow-derived cells did not have plasma lipid alteration compared with their miR155-WT chimeric controls (data not shown), but had significantly reduced atherosclerosis in aortic root ( Figure 6A-6F ). Using laser capture microdissection, we collected atherosclerotic lesions from the aortic root. Figure VII in the online-only Data Supplement shows images of aortic root section before and after the atherosclerotic lesion was removed by laser capture microdissection. qRT-PCR confirmed that in the lesions of the recipients of DKO bone marrow, the mRNA expression of miR155 targets B-cell lymphoma 6 protein and SOCS-1 was significantly increased compared with that in recipients of apoE −/− bone marrow ( Figure 6G ). Proinflammatory chemokine (C-C motif) ligand-2 expression was decreased in DKO bone marrow recipients; however, TNFα expression showed no difference between apoE −/− bone marrow and DKO bone marrow recipients ( Figure 6C ).
Discussion
miR155 is a unique miR in that it is coded only by 1 gene, called bic, and is the only product of this gene. [28] [29] [30] miR155-deficient mice are the first miR knockout mouse model, 13, 14 providing a unique opportunity to investigate the role of a miR in pathophysiology. miR155 has been demonstrated to play important roles in immunity and inflammation, especially macrophage inflammatory responses, implying that it may also be involved in atherogenesis. Indeed, 2 recent studies have shown that miR155 deficiency in bone marrow cells affected atherosclerosis. However, the results are contradictory. Although one report showed that Western diet-fed LDLR −/− mice transplanted with miR155-deficient bone marrow developed more atherosclerotic lesions than mice received WT bone marrow, indicating that in this model miR155 is atheroprotective, 23 the other showed that bone marrow miR155 deficiency reduced plaque size after partial carotid ligation in apoE −/− mice, suggesting that miR155 is proatherogenic. 24 The primary reason for this contradiction was that miR155 deficiency enhanced macrophage inflammation in hypercholesterolemic LDLR −/− mice as shown in the first study 23 whereas it attenuated macrophage inflammation in another hypercholesterolemic mouse model (apoE −/− mice) as shown in the second study. 24 Our current study provided comprehensive data and demonstrated that whole body or bone marrow miR155 deficiency profoundly reduced macrophage inflammation and atherosclerosis in the aortic root region in Western diet-fed apoE −/− mice. However, atherosclerosis in aortic arch and descending aortic regions was not different between the 2 genotypes. Region-specific effects have been reported in many atherosclerosis studies. 31, 32 In apoE −/− mice fed a Western diet for 3 months, atherosclerotic lesions are most profound in the aortic root, whereas lesions are relatively scant in the descending region. It is possible that lack of significant difference in the descending region was because of relatively small lesions in this region. However, the definitive mechanism of this region-specific effect remains to be defined.
In agreement with the recently published study, 24 we found that miR155 expression was increased in both mouse and human atherosclerotic lesions. We confirmed that minimally oxidized LDL and LPS stimulated macrophage miR155 expression via TLR4dependent pathway. Moreover, we showed a positive correlation between miR155 expression level and proinflammatory cytokine expression level in macrophages of various genotypes and under varied treatment including cholesterol loading. Furthermore, using both gain-of-function and loss-of-function approaches, we showed that baseline expression of miR155 substantially affected inflammatory responses of macrophages to TLR ligands. In addition, consistent with previous reports, we found that miR155 suppressed the expression of SOCS-1, a negative feedback protein of macrophage inflammation. 21, 33 This was also confirmed in vivo by laser capture microdissection and qPCR. In atherosclerotic lesions of apoE/miR155 DKO bone marrow recipient mice, the expression of SOCS-1 and another miR155 target, B-cell lymphoma 6 protein, was significantly increased compared with that in the lesions of apoE −/− bone marrow recipient mice. Our data strongly suggest that in macrophages proinflammatory cytokines and miR155 may reciprocally regulate each other, and thus miR155-targeting strategies may lead to macrophage inflammation suppression. Donners et al 23 showed that in normal conditions, miR155 ablation attenuated inflammatory responses in macrophages, whereas in oxidized LDL-loaded macrophage foam cells, miR155 deficiency paradoxically promoted a more proinflammatory phenotype. We, however, found that macrophages from Western diet-fed apoE/miR155 DKO mice produced less proinflammatory cytokines either at baseline or under LPS stimulation compared with the macrophages from Western diet-fed apoE −/− mice. The reason for this discrepancy is unknown, possibly because of an unknown alteration caused in their study by in vitro oxidized LDL loading or in vivo excessive cholesterol overloading in Western diet-fed LDLR −/− mice whose plasma total cholesterol level may reach ≈1500 mg/dL, 23 which is exceptionally high (in our study, the plasma cholesterol level of the mice at the end point was 700-750 mg/dL). In addition, the status of apoE may alter significantly the function of miR155 in macrophages. The exact reasons for the difference in the 2 different models warrant further investigation.
Macrophage inflammation and cholesterol accumulation are closely linked together in atherogenesis. 34 Imbalance between cholesterol uptake and efflux in the context of hyperlipidemia leads to macrophage foam cell formation, which is an obligatory step of atherogenesis. In this study, we demonstrated for the first time that overexpression of miR155 compromised whereas miR155 deficiency improved cholesterol efflux from acetylated LDL-loaded macrophages. Mechanistically, we demonstrated that the enhanced cholesterol efflux by miR155 deficiency in macrophages was not because of increased expression of cholesterol transporters ABCA1 and ABCG1, rather at least partially because of increased autophagy. Autophagy is a cellular process that assists the cell to achieve a homeostasis under stress. Recently, elegant work by Ira Tabas and colleagues has shown that macrophage autophagy plays an antiatherogenic role, 35 and Yves Marcel and colleagues further demonstrated that autophagy was activated in macrophage foam cells and facilitated ABCA1-mediated cholesterol efflux. 26, 27 Previous studies have shown that miR155 knockout impaired the activation of Akt. 36 Inhibition of Akt pathway has been shown to induce autophagy. 37 Moreover, Akt1 inhibits miR155 expression in macrophages, which would constitute a negative feedback loop. 21, 38 However, the detailed mechanism by which miR155 regulates macrophage autophagy and cholesterol efflux warrants further investigation. Consistent with the cholesterol efflux result, the atherosclerotic lesions in DKO mice contained less Oil Red O-stained region and fewer macrophages than those in apoE −/− mice. While we were revising this article, 2 groups reported that miR155 may modulate macrophage autophagy on Mycobacteria infection. One report showed that forced miR155 expression accelerated the autophagic response in macrophages, 39 whereas the other study found that miR155 inhibited interferon-γ-induced autophagy. 40 These results indicate that the role of miR155 in macrophage autophagy is complex and context dependent.
In addition to macrophage functional alteration because of miR155 deficiency, we also found that miR155 deficiency resulted in an overall antiatherogenic spleen leukocyte profile, evidenced by increased regulatory T cell and reduced CD11b+/Ly6C high cell percentages. miR155 has been suggested to confer competitive fitness to regulatory T cells 33 ; the increased regulatory T cells in miR155 −/− mice in our study reflect the possibility that the effects of miR155 on regulatory T cell may be altered by hyperlipidemia. Many studies have The cells were treated with vehicle or lipopolysaccharide (LPS; 100 ng/mL) for 6 hours before total RNAs were extracted for quantitative polymerase chain reaction quantification of inflammatory cytokine expression (*P<0.01; n=8). B, Macrophages from the mice were cultured with or without addition of LPS (100 ng/mL) in the medium for 24 hours; the cytokine concentrations in the medium were measured by ELISA (n=5). C, Concentrations of cytokines in mouse plasma at the end point were determined by ELISA (n=8). IL-6 indicates interleukin-6; and TNF, tumor necrosis factor.
shown that regulatory T cells are antiatherogenic, 41, 42 whereas CD11b+/Ly6C high cells are proatherogenic. 32, 43 However, our study does not provide direct evidence whether the increased regulatory T cells by miR155 deficiency contribute to reduced atherosclerosis, and it is currently unknown why our observations were different from those in a previous study. 23 Recent studies, including ours, suggested that miR155 modulates macrophage polarization and miR155 deficiency rendered macrophage prone to M2 polarization through activating signal transducer and activator of transcription 6 and CCAAT/ enhancer-binding protein beta pathways, [44] [45] [46] providing additional evidence that miR155 is proinflammatory in macrophages. miR155 is also expressed in vascular endothelial cells and smooth muscle cells besides myeloid cells, and the role in atherogenesis may be conflicting. 24, [47] [48] [49] Actually, recent studies have shown that miR155 affected endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase 39 and attenuated angiotensin II-induced endothelial cell damage and apoptosis. 48 The role of miR155 expression in endothelial cells and smooth muscle cells in atherogenesis warrants further investigation, although the study by Nazari-Jahantigh et al 24 suggested that vascular miR155 seemed not to contribute to atherogenesis. In our current study, we conclude that the myeloid cell miR155 expression is proatherogenic. Inhibition of myeloid cell miR155 expression would yield antiatherogenic benefit through suppressing macrophage inflammatory responses, enhancing macrophage cholesterol efflux, and achieving an antiatherogenic circulating leukocyte profile.
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